Trials / Unknown
UnknownNCT05484050
VEGF in Iris Tissue in Primary Congenital Glaucoma
Estimation of Vascular Endothelial Growth Factor (VEGF) in Iris Tissue in Primary Congenital Glaucoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hassan Lotfy Fahmy · Academic / Other
- Sex
- All
- Age
- 1 Day – 1 Year
- Healthy volunteers
- Not accepted
Summary
Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen in primary congenital glaucoma through Immunohistochemistry.
Detailed description
Combined trabeculotomy with mitomycin C will done in infants with primary congenital glaucoma with histopathological examination of the the peripheral iris tissue specimen and vascular endothelial growth factor (VEGF) estimation in iris tissue specimen through Immunohistochemistry. Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen taking from ocular trauma or congenital cataract used as control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Immunohistochemistry analysis | Estimation of VEGF through Immunohistochemistry |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-03-01
- Completion
- 2023-06-01
- First posted
- 2022-08-02
- Last updated
- 2022-08-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05484050. Inclusion in this directory is not an endorsement.